It was reported that on (b)(6) 2023, a 22mm amplatzer septal occluder was chosen for implant using a 10f amplatzer trevisio intravascular delivery system.During procedure, the sizing of the device determined by the corresponding echocardiographic and angiographic measurement with 18mm amplatzer sizing balloon ii.During procedure, the device had a cobra deformation upon delivery.The device was removed from the patient prior to release from the delivery cable and was exchanged.There was no report of any interaction with cardiac structures during deployment and no report of any angulation/kink noticed with the delivery system.A new 24mm amplatzer septal occluder was chosen and completed the procedure.The patient remained hemodynamically stable throughout the procedure.There was no clinically significant delay in procedure and no adverse consequences to the patient.The patient was reported stable.No additional information was provided.
|
An event of device deformity was reported.Imaging was received from the field appearing to show the device presenting cobra deformation in and out of the body.The device was returned to abbott for investigation and met functional specifications when analyzed under non-physiological conditions.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed, and the product met all defined manufacturing specifications.The cause of the reported incident could not conclusively be determined but could be as result of the use of a larger than recommended delivery system as the use of a larger sheath may influence deformations.Please note, that per the instructions for use, artmt600034451, ifu asd septal occluder abt ous, c the recommended size delivery system for a 22mm asd is a 9f.Na.
|